Boiron S.A.
BOI.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$546.91M
Close$
Share Statistics
| Market cap | $546.91 Million |
|---|---|
| Enterprise Value | $525.03 Million |
| Dividend Yield | $1.35 (7.67%) |
| Earnings per Share | $1.88 |
| Beta | 0.21 |
| Outstanding Shares | 17,362,275 |
Return
| Return on Equity | 12.14% |
|---|---|
| Return on Assets | 8.01% |
| Return on Invested Capital | 9.48% |
Valuation & Multiples
| P/E Ratio | 11.81 |
|---|---|
| PEG | -20.68 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 0.8 |
| Enterprise Value to Revenue | 0.53 |
| Enterprise Value to EBIT | 12.24 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
March 24, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Boiron S.A.
2,634 employees
CEO: Pascal Houdayer Boiron S.A., founded in Messimy, France, in 1932, is a pharmaceutical company dedicated to the production and global sale of homeopathic medicines. Its market presence spans France, the broader European continent, North America, and nume...